Topic: genomics sequencing
Loxo is preparing for a November verdict from the FDA on larotrectinib as a treatment for solid tumors with NTRK fusions.
Merck paired up with Foundation Medicine to develop a pan-cancer diagnostic for Keytruda to measure microsatellite instability and other biomarkers.
Charles River partners with PathoQuest to offer clients NGS solutions for biologics viral contamination testing and cell-line genetic characterization.
The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.
Hannes Smárason chats with FierceBiotech about WuXi NextCODE's technology, products, investments and the road ahead.
WuXi NextCODE tapped Christina Waters, Ph.D., founder and CEO of a pediatric rare disease nonprofit, to lead its rare disease efforts.
Scientists believe they've discovered a novel gene that can be inhibited with antisense technology to treat cancer.
Centogene has raised $28 million to expand its presence in the U.S. and China.
Endometrial cancer is becoming both more prevalent and more deadly, yet there are still no good screening methods to catch the disease in its earliest stages. Scientists at the Icahn School of Medicine at Mount Sinai in New York are working on a solution, and it lies in detecting genetic mutations in the lining of the uterus.
Roche Venture Fund and 5AM Ventures have led benchtop sample preparation upstart Purigen Biosystems to an $18.2 million Series A round.